Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability

Thumbnail Image
Download
Name

nihms828767.pdf

Size

1.12 MB

Format

Adobe PDF

Checksum (MD5)

e01177273f1a3cc89ceeb14acd7a1b04

Download all files submitted through automated deposit
sword-2018-07-12.original.zip (936.39 KB)
Author(s)
Pattabiraman, D. R.
•
Bierie, B.
•
Kober, K. I.
•
Thiru, P.
•
Krall, J. A.
•
Zill, C.
•
Reinhardt, F.
•
Tam, W. L.
Date Issued
January 2016
Journal
Science
Publisher
American Association for the Advancement of Science (AAAS)
Citation
Pattabiraman, D. R. et al. “Activation of PKA Leads to Mesenchymal-to-Epithelial Transition and Loss of Tumor-Initiating Ability.” Science 351, 6277 (March 2016): aad3680 © 2016 American Association for the Advancement of Science
Version
Author's final manuscript
Abstract
The epithelial-to-mesenchymal transition enables carcinoma cells to acquire malignancy-associated traits and the properties of tumor-initiating cells (TICs). TICs have emerged in recent years as important targets for cancer therapy, owing to their ability to drive clinical relapse and enable metastasis. Here, we propose a strategy to eliminate mesenchymal TICs by inducing their conversion to more epithelial counterparts that have lost tumor-initiating ability. We report that increases in intracellular levels of the second messenger, adenosine 3',5'-monophosphate, and the subsequent activation of protein kinase A (PKA) induce a mesenchymal-to-epithelial transition (MET) in mesenchymal human mammary epithelial cells. PKA activation triggers epigenetic reprogramming of TICs by the histone demethylase PHF2, which promotes their differentiation and loss of tumor-initiating ability. This study provides proof-of-principle for inducing an MET as differentiation therapy for TICs and uncovers a role for PKA in enforcing and maintaining the epithelial state.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology)
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/116976
DOI of Published Version
https://doi.org/10.1126/SCIENCE.AAD3680
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.